300 related articles for article (PubMed ID: 29565225)
1. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
Seok H; Kang CI; Huh K; Cho SY; Ha YE; Chung DR; Peck KR
Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study.
Kang CI; Song JH; Kim SH; Chung DR; Peck KR; So TM; Hsueh PR;
Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):55-9. PubMed ID: 24062235
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
4. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema].
Carlavilla AB; López-Medrano F; Chaves F; Villena V; Echave-Sustaeta J; Aguado JM
Enferm Infecc Microbiol Clin; 2005 May; 23(5):270-3. PubMed ID: 15899177
[TBL] [Abstract][Full Text] [Related]
5. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
[TBL] [Abstract][Full Text] [Related]
6. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone-nonsusceptible Streptococcus pneumoniae isolates from a medical center in the pneumococcal conjugate vaccine era.
Chen HH; Li HC; Su LH; Chiu CH
J Microbiol Immunol Infect; 2017 Dec; 50(6):839-845. PubMed ID: 27342636
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
Fogarty CM; Greenberg RN; Dunbar L; Player R; Marrie TJ; Kojak CM; Morgan N; Williams RR
Clin Ther; 2001 Mar; 23(3):425-39. PubMed ID: 11318077
[TBL] [Abstract][Full Text] [Related]
9. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
Yayan J
Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
[TBL] [Abstract][Full Text] [Related]
10. Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial.
Fujita J; Niki Y; Kadota J; Yanagihara K; Kaku M; Watanabe A; Aoki N; Hori S; Tanigawara Y; Cash HL; Kohno S
J Infect Chemother; 2013 Jun; 19(3):472-9. PubMed ID: 23179958
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage.
Pletz MW; van der Linden M; von Baum H; Duesberg CB; Klugman KP; Welte T;
Int J Med Microbiol; 2011 Jan; 301(1):53-7. PubMed ID: 20692869
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for treatment of pneumonia in intensive care units].
Emmi V
Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
[TBL] [Abstract][Full Text] [Related]
13. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
Hsieh YC; Chang LY; Huang YC; Lin HC; Huang LM; Hsueh PR
Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?
Bauer T; Ewig S; Marcos MA; Schultze-Werninghaus G; Torres A
Med Clin North Am; 2001 Nov; 85(6):1367-79. PubMed ID: 11680107
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae.
Isea-Peña MC; Sanz-Moreno JC; Esteban J; Fernández-Roblas R; Fernández-Guerrero ML
Infection; 2013 Oct; 41(5):935-9. PubMed ID: 23709294
[TBL] [Abstract][Full Text] [Related]
16. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
[TBL] [Abstract][Full Text] [Related]
17. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
Lee S; Kim SH; Park M; Bae S
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):227-31. PubMed ID: 23623384
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
